309 related articles for article (PubMed ID: 24956279)
1. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.
Huang W; Yao Y; Long Q; Yang X; Sun W; Liu C; Jin X; Li Y; Chu X; Chen B; Ma Y
PLoS One; 2014; 9(6):e100727. PubMed ID: 24956279
[TBL] [Abstract][Full Text] [Related]
2. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
[TBL] [Abstract][Full Text] [Related]
3. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
[TBL] [Abstract][Full Text] [Related]
5. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
[TBL] [Abstract][Full Text] [Related]
6. Small protein A and phospholipase D immunization serves a protective role in a mouse pneumonia model of Acinetobacter baumannii infection.
Li H; Tan H; Hu Y; Pan P; Su X; Hu C
Mol Med Rep; 2017 Aug; 16(2):1071-1078. PubMed ID: 28586022
[TBL] [Abstract][Full Text] [Related]
7. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
[TBL] [Abstract][Full Text] [Related]
8. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
Singh R; Capalash N; Sharma P
Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
[TBL] [Abstract][Full Text] [Related]
9. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
[TBL] [Abstract][Full Text] [Related]
10. A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.
Pulido MR; García-Quintanilla M; Pachón J; McConnell MJ
Vaccine; 2020 Jan; 38(4):719-724. PubMed ID: 31843268
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with outer membrane vesicles (OMV) protects against airway colonization and systemic infection with Acinetobacter baumannii.
Higham SL; Baker S; Flight KE; Krishna A; Kellam P; Reece ST; Tregoning JS
J Infect; 2023 Jun; 86(6):563-573. PubMed ID: 36858180
[TBL] [Abstract][Full Text] [Related]
12. A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice.
Zeng X; Gu H; Cheng Y; Jia KR; Liu D; Yuan Y; Chen ZF; Peng LS; Zou QM; Shi Y
Clin Microbiol Infect; 2019 Apr; 25(4):516.e1-516.e4. PubMed ID: 30583061
[TBL] [Abstract][Full Text] [Related]
13. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
Badmasti F; Ajdary S; Bouzari S; Fooladi AA; Shahcheraghi F; Siadat SD
Mol Immunol; 2015 Oct; 67(2 Pt B):552-8. PubMed ID: 26277277
[TBL] [Abstract][Full Text] [Related]
14. Vesicle-Mediated Dendritic Cell Activation in
Cai W; Kesavan DK; Cheng J; Vasudevan A; Wang H; Wan J; Abdelaziz MH; Su Z; Wang S; Xu H
J Immunol Res; 2019; 2019():2835256. PubMed ID: 32083139
[No Abstract] [Full Text] [Related]
15. Development of Different Methods for Preparing
Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
Front Immunol; 2020; 11():1069. PubMed ID: 32655550
[No Abstract] [Full Text] [Related]
16. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
[TBL] [Abstract][Full Text] [Related]
17. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.
García-Quintanilla M; Pulido MR; Pachón J; McConnell MJ
PLoS One; 2014; 9(12):e114410. PubMed ID: 25485716
[TBL] [Abstract][Full Text] [Related]
18. Immunization with recombinant DcaP-like protein and AbOmpA revealed protections against sepsis infection of multi-drug resistant Acinetobacter baumannii ST2
Fereshteh S; Ajdary S; Sepehr A; Bolourchi N; Barzi SM; Haririzadeh Jouriani F; Riazi-Rad F; Shahcheraghi F; Badmasti F
Microb Pathog; 2023 Jan; 174():105882. PubMed ID: 36403713
[TBL] [Abstract][Full Text] [Related]
19. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
McConnell MJ; Rumbo C; Bou G; Pachón J
Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
[TBL] [Abstract][Full Text] [Related]
20. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]